Explore our comprehensive coverage of fda, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA's June 2026 draft guidance on CRISPR safety coincides with a broader reckoning in medical research, exposing the biological limits of chronic ...
Read Full Story →
WorldAn expert impact analysis of the August 2026 mental health landscape, examining the collision betwee...
Medical ResearchAn expert impact analysis of the August 2026 medical research landscape, examining the FDA's acceler...
Nutrition & FitnessHHS and FDA on August 10 proposed mandatory GRAS notifications and submitted the first federal defin...
Mental HealthWashington's codification of telehealth parity, conflicting GLP-1 psychiatric data, and FDA psychede...
HealthThe convergence of 100% API tariffs, FDA-cleared cellular rejuvenation trials, and the financializat...
Medical ResearchAn expert impact analysis exploring how the 2026 implementation of Medicare drug price negotiations ...
